X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs MERCK LTD - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD MERCK LTD WYETH LTD/
MERCK LTD
 
P/E (TTM) x 27.7 26.1 106.2% View Chart
P/BV x 5.3 2.9 183.0% View Chart
Dividend Yield % 1.3 1.0 131.6%  

Financials

 WYETH LTD   MERCK LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
MERCK LTD
Dec-16
WYETH LTD/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,0441,060 98.5%   
Low Rs818623 131.3%   
Sales per share (Unadj.) Rs298.6632.4 47.2%  
Earnings per share (Unadj.) Rs57.245.7 125.2%  
Cash flow per share (Unadj.) Rs58.462.3 93.7%  
Dividends per share (Unadj.) Rs17.0011.00 154.5%  
Dividend yield (eoy) %1.81.3 139.7%  
Book value per share (Unadj.) Rs249.5388.8 64.2%  
Shares outstanding (eoy) m22.7216.60 136.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.3 234.4%   
Avg P/E ratio x16.318.4 88.4%  
P/CF ratio (eoy) x15.913.5 118.1%  
Price / Book Value ratio x3.72.2 172.5%  
Dividend payout %29.724.1 123.4%   
Avg Mkt Cap Rs m21,15713,969 151.5%   
No. of employees `0000.51.6 31.1%   
Total wages/salary Rs m4001,487 26.9%   
Avg. sales/employee Rs Th13,787.46,631.9 207.9%   
Avg. wages/employee Rs Th813.0939.2 86.6%   
Avg. net profit/employee Rs Th2,643.3479.4 551.4%   
INCOME DATA
Net Sales Rs m6,78310,498 64.6%  
Other income Rs m353242 145.5%   
Total revenues Rs m7,13610,741 66.4%   
Gross profit Rs m1,6171,135 142.5%  
Depreciation Rs m27276 9.7%   
Interest Rs m60-   
Profit before tax Rs m1,9381,102 175.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632343 184.2%   
Profit after tax Rs m1,301759 171.4%  
Gross profit margin %23.810.8 220.5%  
Effective tax rate %32.631.1 104.7%   
Net profit margin %19.27.2 265.2%  
BALANCE SHEET DATA
Current assets Rs m6,9846,410 109.0%   
Current liabilities Rs m2,0568,828 23.3%   
Net working cap to sales %72.6-23.0 -315.3%  
Current ratio x3.40.7 467.9%  
Inventory Days Days9958 172.1%  
Debtors Days Days2438 62.4%  
Net fixed assets Rs m2441,406 17.4%   
Share capital Rs m227166 136.9%   
"Free" reserves Rs m5,4416,286 86.6%   
Net worth Rs m5,6686,455 87.8%   
Long term debt Rs m250-   
Total assets Rs m7,9018,828 89.5%  
Interest coverage x353.3NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 72.2%   
Return on assets %16.58.6 192.3%  
Return on equity %22.911.8 195.1%  
Return on capital %34.017.1 199.4%  
Exports to sales %0.28.3 2.6%   
Imports to sales %36.321.0 172.7%   
Exports (fob) Rs m15869 1.7%   
Imports (cif) Rs m2,4652,209 111.6%   
Fx inflow Rs m15959 1.6%   
Fx outflow Rs m2,6772,612 102.5%   
Net fx Rs m-2,662-1,653 161.0%   
CASH FLOW
From Operations Rs m9231,070 86.2%  
From Investments Rs m317-750 -42.3%  
From Financial Activity Rs m-481-150 321.1%  
Net Cashflow Rs m759171 444.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 51.8 98.6%  
Indian inst/Mut Fund % 11.3 18.2 62.1%  
FIIs % 7.2 1.0 720.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 29.1 104.5%  
Shareholders   21,978 28,591 76.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   CIPLA  PFIZER  NATCO PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - CLARIS LIFESCIENCES COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS